APE fundamentals
An in-depth look to ADDEX THERAPEUTICS LTD operating, investing, and financing activities
APE free cash flow for Q2 24 is -2.86 M EUR. For 2023, APE free cash flow was -8.56 M EUR and operating cash flow was -8.56 M EUR.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM